These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure. Morgan PG; Georghiou M; Flynn F; Jaggar S Br J Anaesth; 2007 Jul; 99(1):143; author reply 143-4. PubMed ID: 17573400 [No Abstract] [Full Text] [Related]
6. Beneficial effects of N-acetylcysteine and ebselen on renal ischemia/reperfusion injury. Kizilgun M; Poyrazoglu Y; Oztas Y; Yaman H; Cakir E; Cayci T; Akgul OE; Kurt YG; Yaren H; Kunak ZI; Macit E; Ozkan E; Taslipinar MY; Turker T; Ozcan A Ren Fail; 2011; 33(5):512-7. PubMed ID: 21545313 [TBL] [Abstract][Full Text] [Related]
7. Commentary on "N-acetylcysteine (NAC) protects against acute kidney injury following prolonged pneumoperitoneum". Shebrain S J Surg Res; 2011 Dec; 171(2):e179-80. PubMed ID: 22001183 [No Abstract] [Full Text] [Related]
8. A drug to prevent renal failure? Kellum JA Lancet; 2003 Aug; 362(9384):589-90. PubMed ID: 12944054 [No Abstract] [Full Text] [Related]
9. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). ACT Investigators Circulation; 2011 Sep; 124(11):1250-9. PubMed ID: 21859972 [TBL] [Abstract][Full Text] [Related]